FDA Approved Saphnelo™ (Anifrolumab-fnia) as a New Treatment for Lupus
The Drug The U.S. Food and Drug Administration (FDA) has approved Saphnelo™ (anifrolumab-fnia) as a treatment for adults with systemic lupus erythematosus (SLE) who are receiving standard therapy. It is the third U.S. FDA approval of a lupus therapy since…